We are hiring!

Paraza Pharma, Inc. is growing and looking for smart passionate people to join our team. Multiple positions are available in our Chemical Sciences department. Please follow the link below to learn how to join our dynamic team!

Learn More
September 17, 2021 | News

Paraza Pharma makes the headlines.

In a complete article on the life sciences revitalization in Montreal, the newspaper La Presse (about 160 000 impressions) highlighted the remarkable contribution of Paraza Pharma to this sustained effort of companies established in Montreal. We invite you to read it via this link: https://www.lapresse.ca/affaires/portfolio/2021-09-16/montreal-pole-sante/paraza-pharma-nee-de-la-crise-et-symbole-de-la-renaissance.php.  We are proud of the work accomplished over the years and want to thank the entire Paraza Pharma team who have been involved in our breakthrough in life sciences in Montreal and around the world.

August 3, 2021 | News

A paper disclosing a retrospective analysis of the influence the binding sites and their location relative to the cell membrane on the optimization of two distinct series of TRPA1 antagonists was just published in the ACS Medicinal Chemistry Letters. This work was conducted in collaboration with Genentech.

Elisia Villemure, Jack A. Terrett, Robin Larouche-Gauthier, Martin Déry, Huifen Chen, Rebecca M. Reese, Shannon D. Shields, Jun Chen, Steven Magnuson, and Matthew Volgraf, ACS Med. Chem. Lett. 2021, ASAP – A Retrospective Look at the Impact of Binding Site Environment on the Optimization of TRPA1 Antagonists.


July 20, 2021 | News

NIMIUM Therapeutics and Paraza Pharma form partnership to develop new medicines to treat cardiometabolic diseases (CMDs), obesity and type 2 diabetes.

Read More


Load more